Harel Insurance Investments & Financial Services Ltd. Novo Cure LTD Transaction History

Harel Insurance Investments & Financial Services Ltd.

  • $5.16 Billion
  • Q1 2024

A detailed history of Harel Insurance Investments & Financial Services Ltd. transactions in Novo Cure LTD stock. As of the latest transaction made, Harel Insurance Investments & Financial Services Ltd. holds 1,063 shares of NVCR stock, worth $17,858. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,063
Previous 1,366 22.18%
Holding current value
$17,858
Previous $20,000 15.0%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024
SELL
$12.42 - $17.29 $3,763 - $5,238
-303 Reduced 22.18%
1,063 $17,000
Q4 2023

Jan 30, 2024
SELL
$11.13 - $15.78 $2,582 - $3,660
-232 Reduced 14.52%
1,366 $20,000
Q3 2023

Oct 30, 2023
BUY
$16.15 - $42.35 $12,403 - $32,524
768 Added 92.53%
1,598 $26,000
Q2 2023

Jul 17, 2023
SELL
$40.29 - $82.51 $25,785 - $52,806
-640 Reduced 43.54%
830 $34,000
Q1 2023

May 02, 2023
BUY
$56.44 - $118.81 $36,686 - $77,226
650 Added 79.27%
1,470 $88,000
Q4 2022

Jan 26, 2023
SELL
$63.98 - $85.37 $7,677 - $10,244
-120 Reduced 12.77%
820 $60,000
Q3 2022

Oct 31, 2022
SELL
$67.99 - $89.57 $4,555 - $6,001
-67 Reduced 6.65%
940 $72,000
Q2 2022

Jul 19, 2022
SELL
$56.6 - $89.9 $27,507 - $43,691
-486 Reduced 32.55%
1,007 $70,000
Q1 2022

May 03, 2022
SELL
$60.15 - $84.52 $33,804 - $47,500
-562 Reduced 27.35%
1,493 $124,000
Q4 2021

Feb 07, 2022
BUY
$75.08 - $121.99 $154,289 - $250,689
2,055 New
2,055 $164,000
Q3 2020

Oct 20, 2020
SELL
$58.05 - $111.31 $116,100 - $222,620
-2,000 Closed
0 $0
Q2 2020

Jul 14, 2020
BUY
$57.2 - $74.41 $114,400 - $148,820
2,000 New
2,000 $119,000

Others Institutions Holding NVCR

# of Institutions
277
Shares Held
73.2M
Call Options Held
1.43M
Put Options Held
832K
View Full List

About NovoCure Ltd

NVCR Quotes by TradingView
  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $1.76B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Harel Insurance Investments & Financial Services Ltd. Portfolio

Follow Harel Insurance Investments & Financial Services Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harel Insurance Investments & Financial Services Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Harel Insurance Investments & Financial Services Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email